Involvement of endothelial progenitor cells in tumor vascularization

Microvascular Research

Volumn 79, Issue 3, 2010, Pages 217-223

  Patenaude, Alexandre ^a   Parker, Jeremy ^a   Karsan, Aly ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Endothelial progenitor cell; Hemangioblast; Hematopoietic stem cell; Marrow derived cell; Mesenchymal cell; Monocyte; Neovascularization; Tumor; Vascular endothelial growth factor receptor 2; Vasculogenesis

Indexed keywords

CD133 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CD34 SELECTION; CELL DIFFERENTIATION; CELL FUSION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL WALL; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HEMANGIOBLAST; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MICROSCOPE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STEM CELL MOBILIZATION; TUMOR VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; ENDOTHELIAL CELLS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; STEM CELLS;

EID: 77952099582     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.01.007     Document Type: Article

References (83)

1. Ahn G.O., Brown J.M. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008, 13:193-205.
2. Ahn G.O., Brown J.M. Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature. Angiogenesis 2009, 12:159-164.
3. Aicher A., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res. 2007, 100:581-589.
4. Alvarez-Dolado M., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003, 425:968-973.
5. Annabi B., et al. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J. Cell. Biochem. 2004, 91:1146-1158.
6. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
7. Bailey A.S., et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13156-13161.
8. Beckermann B.M., et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br. J. Cancer 2008, 99:622-631.
9. Bertolini F., et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev. Cancer 2006, 6:835-845.
10. Bhatia M. AC133 expression in human stem cells. Leukemia 2001, 15:1685-1688.
11. Bussolati B., et al. Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J. 2008, 22:3696-3705.
12. Chapel A., et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J. Gene Med. 2003, 5:1028-1038.
13. Conejo-Garcia J.R., et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 2004, 10:950-958.
14. Conejo-Garcia J.R., et al. Vascular leukocytes contribute to tumor vascularization. Blood 2005, 105:679-681.
15. Dan Y.Y., Yeoh G.C. Liver stem cells: a scientific and clinical perspective. J. Gastroenterol. Hepatol. 2008, 23:687-698.
16. Davani S., et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003, 108(Suppl 1):II253-II258.
17. De Palma M., et al. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 2003, 9:789-795.
18. Duda D.G., et al. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J. Clin. Oncol. 2006, 24:1449-1453.
19. Elshal M.F., et al. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005, 106:2923-2924.
20. Fernandez Pujol B., et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 2000, 65:287-300.
21. Gao D., Mittal V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol. Med. 2009, 15:333-343.
22. Gao D., et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319:195-198.
23. Garcia-Barros M., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
24. Gehling U.M., et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000, 95:3106-3112.
25. Gill M., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ. Res. 2001, 88:167-174.
26. Gothert J.R., et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004, 104:1769-1777.
27. Grant M.B., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 2002, 8:607-612.
28. Grunewald M., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
29. Hall B., et al. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb. Exp. Pharmacol. 2007, 263-283.
30. Harraz M., et al. CD34-blood-derived human endothelial cell progenitors. Stem Cells 2001, 19:304-312.
31. Hilbe W., et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J. Clin. Pathol. 2004, 57:965-969.
32. Hung S.C., et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. 2005, 11:7749-7756.
33. Igreja C., et al. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica 2007, 92:469-477.
34. Ingram D.A., et al. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005, 105:2783-2786.
35. Kuwana M., et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J. Leukoc. Biol. 2003, 74:833-845.
36. Kuwana M., et al. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells 2006, 24:2733-2743.
37. Larrivee B., Karsan A. Involvement of marrow-derived endothelial cells in vascularization. Handb. Exp. Pharmacol. 2007, 89-114.
38. Larrivee B., et al. Minimal contribution of marrow-derived endothelial precursors to tumor vasculature. J. Immunol. 2005, 175:2890-2899.
39. Larrivee B., et al. Tissue distribution of endothelial cells in vivo following intravenous injection. Exp. Hematol. 2006, 34:1741-1745.
40. Li B., et al. Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res. 2009, 69:338-348.
41. Li W., et al. Endothelial cells in the early murine yolk sac give rise to CD41-expressing hematopoietic cells. Stem Cells Dev. 2005, 14:44-54.
42. Li B., et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 2006, 20:1495-1497.
43. Lin Y., et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 2000, 105:71-77.
44. Liu Z.J., et al. Trafficking and differentiation of mesenchymal stem cells. J. Cell. Biochem. 2009, 106:984-991.
45. Lobe C.G., et al. Z/AP, a double reporter for cre-mediated recombination. Dev. Biol. 1999, 208:281-292.
46. Long M.A., Rossi F.M. Silencing inhibits Cre-mediated recombination of the Z/AP and Z/EG reporters in adult cells. PLoS One 2009, 4:e5435.
47. Lyden D., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001, 7:1194-1201.
48. Machein M.R., et al. Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol. 2003, 13:582-597.
49. Mukouyama Y., et al. In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region. Immunity 1998, 8:105-114.
50. Murdoch C., et al. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008, 8:618-631.
51. Naik R.P., et al. Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res. Treat. 2008, 107:133-138.
52. Newman P.J. The biology of PECAM-1. J. Clin. Invest. 1997, 100:S25-S29.
53. Nolan D.J., et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 2007, 21:1546-1558.
54. Peichev M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
55. Pomyje J., et al. Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells. Eur. J. Haematol. 2003, 70:143-150.
56. Pratt C.I., et al. Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids. Cancer Genet. Cytogenet. 1992, 59:180-190.
57. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
58. Prokopi M., et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009, 114:723-732.
59. Purhonen S., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6620-6625.
60. Rafii S., et al. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther. 2002, 9:631-641.
61. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712.
62. Rajantie I., et al. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 2004, 104:2084-2086.
63. Rehman J., et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
64. Rigolin G.M., et al. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood 2006, 107:2531-2535.
65. Romagnani P., et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ. Res. 2005, 97:314-322.
66. Ruggeri Z.M. Von Willebrand factor. Curr. Opin. Hematol. 2003, 10:142-149.
67. Shaked Y., et al. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 2005, 7:101-111.
68. Shaked Y., et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006, 313:1785-1787.
69. Shaked Y., et al. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008, 14:263-273.
70. Shi Q., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
71. Shinde Patil V.R., et al. Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma. Neoplasia 2005, 7:234-240.
72. Smith R.A., Glomski C.A. "Hemogenic endothelium" of the embryonic aorta: does it exist?. Dev. Comp. Immunol. 1982, 6:359-368.
73. Spring H., et al. Chemokines direct endothelial progenitors into tumor neovessels. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18111-18116.
74. Streubel B., et al. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N. Engl. J. Med. 2004, 351:250-259.
75. Tamura H., et al. In vivo differentiation of stem cells in the aorta-gonad-mesonephros region of mouse embryo and adult bone marrow. Exp. Hematol. 2002, 30:957-966.
76. Tavian M., et al. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood 1996, 87:67-72.
77. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 2004, 95:343-353.
78. Yamazaki M., et al. Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells. Cancer Sci. 2008, 99:1131-1138.
79. Zengin E., et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 2006, 133:1543-1551.
80. Zentilin L., et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006, 107:3546-3554.
81. Zhao Y., et al. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2426-2431.
82. Ziegelhoeffer T., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 2004, 94:230-238.
83. Zovein A.C., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008, 3:625-636.